Dr Jane Wolstenholme is a health economist based at the Health Economics Research Centre. Her main research interests lie in the areas of economic evaluation and health technology assessment from applied and methodological perspectives. She has been involved with a variety of projects including modelling the cost-effectiveness of prostate cancer screening and cervical cancer screening; economic evaluation alongside a RCT for the treatment of subarachnoid aneurysm; assessing the usefulness of cost-effectiveness data in priority setting.